COVID-19 rapid test

for antigensSARS-COV-2nasopharyngeal

This kit is used for the quaitative detection of the COVID-2019-NP antigen in human nasopharyngeal swab and oropharyngeal swab samples. It is mainly used for clinical reference, but cannot be used as the basis of diagnosis of the COVID-2019. Detection Principle This kit uses the principle of highly specifc antibody-antigen reaction and clloidal gold labeling immunochromalographic analysis technology. The reagent contains COVID-2019-NP antigen monoclonal anibody prefixed in the lest area (m on the membrane and the COVID-2019-NP Antigen monoclonal anbody coated on the label pad-olloidail gold mixlure.The sample is drpped into the sample well and reacts wth the COVID-2019.NP antigen monoconal antibody which is bound to the pre-coated clloidal gold particles when testing.Then the mixture is chromatographed upwards wilh callaly efeets. i is posive. The antibody labeled by clloidal gold particles will first bind to the COVID-2019-NP antigen virus in the sample during chromatography Then the conjugates are bound by the COVID-2019-NP anigen monoclonal antibody fxed on the memBrane, and a red line appears in the test area (T),fi is negaive, there's no red line in the test area(T).Whether the sample contains COVID-2019 or not, a red line wil appear in the qualty control area (C) The red line appearing in the qualy control area (C) is the standard tor Judging whether there are enough samples and whether the chromalographic process is normal, and it also serves as the internal control standard for the reagent.